Navigation Links
eHCGInjections Announces New Article; Doctor Contradicts FDA Take on HCG Injections for Weight Loss
Date:7/18/2013

LOS ANGELES, July 18, 2013 /PRNewswire-iReach/ -- The website HCG Injections (ehcginjections.com) aims to educate people on the safe use of Human Chorionic Gonadotropin (HCG) injections as part of a weight loss program. It is updated regularly with helpful articles on the topic and information on popular weight loss programs that incorporate HCG injections as part of their regimen. The site announced the addition of a new article to its library entitled, "Do HCG Injections Help with Weight Loss? A Physician's Opinion."

(Photo: http://photos.prnewswire.com/prnh/20130718/MN49410)

In the article, its author, Dr. Joseph Jamison, a specialist in nutrition and weight loss, takes a somewhat controversial stance on HCG injections that opposes what the FDA has communicated about their effectiveness. According to the article, although studies have shown that HCG injections can help people who've struggled to lose weight through other methods, they have only officially been approved by the FDA for the treatment of male and female infertility. In fact, the FDA issued a statement on HCG injections for weight loss claiming, "There is no supportive evidence that HCG is effective for weight loss."

Dr. Jamison is firm on his stance in the new article. "Using the natural hormone HCG, I have personally observed the physical transformation of men and women who could not otherwise lose weight," he writes. "My program combines HCG injections with a short term very low calorie diet, and my own observational studies have shown excellent weight loss and health improvement results."

For those who decide to try HCG injections for weight loss, the ehcginjections.com site offers and recommends Trim HCG Injections. The products come as part of a kit marketed by Trim Nutrition that includes everything people need to self-inject the HCG compound, and a complete day by day dietary guide to aid in getting people to their weight loss goal. Customers also get a free initial consultation with an account representative who can assist them in devising a custom weight loss program. Visitors to the site can also access Trim B12 Injections, an alternative choice for weight loss. The B12 supplement increases metabolism, boosts energy levels, decreases hunger pangs, and encourages normal sleep patterns – making dieters more rested and motivated to adhere to their weight loss journey.

About eHCGInjections.com

eHCGInjections.com is a site intended to educate people on the safe and effective use of HCG injections for weight loss. It is regularly updated with expert written articles, research and information on various weight loss programs that incorporate the use of HCG compounds. For more information, visit: http://ehcginjections.com

Media Contact: Jack Almeida, eHCGInjections.com, (949) 555-2861, admin@rocketfactor.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE eHCGInjections.com
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... June 28, 2017 Michael Zasloff , ... University School of Medicine, and Founder, Chairman and CEO ... study that has helped clarify the function of alpha-Synuclein ... other neurodegenerative diseases. Denise Barbut , MD, FRCP, ... was senior co-author of the study. Published ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... three research projects accepted for presentation at the 33rd Annual Meeting of the ... – including some of the world’s top thought leaders in reproductive medicine – ...
(Date:6/28/2017)... and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics computational fluid ... enable automated product design exploration and optimization. STAR-CCM+ version 12.04 introduces Design ...
(Date:6/28/2017)... NC (PRWEB) , ... June 28, 2017 , ... Studies ... might lead to an effective treatment for Parkinson’s disease. But what has not been ... should take place to gain the best results. , A new study coming out ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):